Φορτώνει......

Identification of plasma microRNA profiles for primary resistance to EGFR-TKIs in advanced non-small cell lung cancer (NSCLC) patients with EGFR activating mutation

BACKGROUND: EGFR mutation is a strong predictor of efficacy of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKIs) therapy in advanced non-small cell lung cancer (NSCLC). However, around 20–30 % of EGFR-mutated cases showed no response to EGFR-TKIs, suggesting that other determina...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:	J Hematol Oncol
Κύριοι συγγραφείς:	Wang, Shuhang, Su, Xiaomei, Bai, Hua, Zhao, Jun, Duan, Jianchun, An, Tongtong, Zhuo, Minglei, Wang, Zhijie, Wu, Meina, Li, Zhenxiang, Zhu, Jian, Wang, Jie
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	BioMed Central 2015
Θέματα:	Research
Διαθέσιμο Online:	https://ncbi.nlm.nih.gov/pmc/articles/PMC4643502/ https://ncbi.nlm.nih.gov/pubmed/26563758 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-015-0210-9
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Identification of plasma microRNA profiles for primary resistance to EGFR-TKIs in advanced non-small cell lung cancer (NSCLC) patients with EGFR activating mutation

Παρόμοια τεκμήρια